Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AdvanDx
Data presented on impact of rapid testing with PNA FISH in managing bloodstream infections
November 7th, 2006
In conjunction with the recently concluded 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, Graeme Forrest, MD, infectious diseases physician and director of antimicrobial utilization at the University of Maryland Medical Center (UMMC), presented data on the impact that rapid testing with PNA FISH has on patient care. Since 2003, UMMC has incorporated PNA FISH results into treatment algorithms for managing patients with bloodstream infections. PNA FISH is a genetics-based molecular diagnostic assay that provides species identification for bacteria and yeast directly from positive blood cultures. While...
Source: Drug Law Weekly (2006-11-07)
|
